| Products and Services |
Categories |
Atugen's AtuRNAi molecules are applicable for a variety of disease indications. Currently Atugen and its collaboration partners have lead molecules in pre-clinical development for a variety of therapeutic indications. Clinical development of AtuRNAi therapeutic molecules for systemic applications in Atugen's oncology programs are targeted to start soon. |
|
Fields marked as * are mandatory
|
|
| *Message |
|
| Contact Details |
Robert-Rössle-Str. 10
Berlin
D-13125
Germany
Tel: 49-30-9489-2800 |
|
| *Request
Type |
|
| *Email |
|
| *First
Name |
|
| *Last
Name |
|
| Address 1 |
|
| Address 2 |
|
| City |
|
| State |
|
| *Country |
|
| Zip |
|
| *Organization |
|
| *Telephone |
|
| Extension |
|
| Designation |
|
| Other |
|
|
Industry |
|
|
Other |
|
Preferred
Method Of
Contact |
If Other
Specify
|
|
|
